Tradewinds Capital Management, LLC Eli Lilly & CO Transaction History

Tradewinds Capital Management, LLC

$372 Million
Q3 2024

A detailed history of Tradewinds Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 255 shares of LLY stock, worth $202,895. This represents 0.06% of its overall portfolio holdings.

Number of Shares

255

Previous 270 5.56%

Holding current value

$202,895

Previous $244,000 7.79%

% of portfolio

0.06%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$772.14 - $960.02 $11,582 - $14,400	-15 Reduced 5.56%	255 $225,000
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $3,624 - $4,545	5 Added 1.89%	270 $244,000
Q1 2024 Apr 18, 2024	SELL	$592.2 - $792.28 $20,727 - $27,729	-35 Reduced 11.67%	265 $206,000
Q1 2023 Apr 10, 2023	BUY	$310.63 - $364.82 $40,381 - $47,426	130 Added 76.47%	300 $103,000
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $14,469 - $16,860	45 Added 36.0%	170 $0
Q3 2022 Oct 18, 2022	SELL	$296.48 - $337.87 $7,412 - $8,446	-25 Reduced 16.67%	125 $40,000
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $423,390 - $497,123	-1,519 Reduced 91.01%	150 $49,000
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $11,734 - $14,583	-50 Reduced 2.91%	1,669 $478,000
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $11,242 - $13,952	50 Added 3.0%	1,719 $475,000
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $722 - $934	4 Added 0.24%	1,669 $383,000
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $34,214 - $42,377	320 Added 23.79%	1,665 $219,000
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $103,659 - $115,051	1,345	1,345 $115,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.

Account

Tradewinds Capital Management, LLC Eli Lilly & CO Transaction History